Abstract

we became interested in dihydrofuranyl phosphonate that would provide different constraint to the linker between phosphonate and the base. The dihydrofuran ring will serve as a rigid linker between purine/pyrimidine bases and phosphonyl groups of nucleotide inhibitors. A similar concept was introduced in a re-cent reports of dihydrofuryl nucleoside analogs that were shown to be anti-HCMV with resistance to enzymatic degradation,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call